S431-0522 Screening compound: 4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

S431-0522 Screening compound: 4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide
S431-0522 Screening compound: 4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S431-0522
4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S431-0522

Molecular Formula

C26H35N3O3 (C26 H35 N3 O3)

Compound Name

4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

IUPAC name

4-[benzyl(methyl)amino]-N-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecane-9-carboxamide

SMILES

CN(Cc1ccccc1)C1CC(CC2)(CCN2C(NCc(cc2)ccc2OC)=O)OCC1

InChI

InChI=1S/C26H35N3O3/c1-28(20-22-6-4-3-5-7-22)23-12-17-32-26(18-23)13-15-29(16-14-26)25(30)27-19-21-8-10-24(31-2)11-9-21/h3-11,23H,12-20H2,1-2H3,(H,27,30)/t23-/m1/s1

InChI Key

KULYNLLUQIYWGN-HSZRJFAPSA-N

MDL Number (MFCD)

MFCD29008123

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.049

Distribution Coefficient, logD

2.324

Water Solubility, LogSw

-3.28

Polar Surface Area

43.771

Acid Dissociation Constant (pKa)

15.52

Base Dissociation Constant (pKb)

8.03

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

S431-0522 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

CNS BBB Library (22607 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S431-0522 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S431-0522?
Check Price and Availability of S431-0522, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S431-0522 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S431-0522
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S431-0522
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S431-0522 available by request